Adil I. Khan, MSc, PhD, Associate Professor of Pathology and Laboratory Medicine at the Lewis Katz School of Medicine at Temple University, Director of Point-of-Care Testing and Clinical Chemistry at Temple University Hospital and Temple University Hospital-Episcopal Campus, and Director of the Clinical Chemistry Laboratory at Temple University Hospital and Temple University Hospital-Episcopal Campus, offered insight for an American Association for Clinical Chemistry (AACC) article about implementing a new hypoglycemia target.